426 related articles for article (PubMed ID: 15486975)
21. Tbx5 specifies the left/right ventricles and ventricular septum position during cardiogenesis.
Takeuchi JK; Ohgi M; Koshiba-Takeuchi K; Shiratori H; Sakaki I; Ogura K; Saijoh Y; Ogura T
Development; 2003 Dec; 130(24):5953-64. PubMed ID: 14573514
[TBL] [Abstract][Full Text] [Related]
22. Assembly of a bZIP-bHLH transcription activation complex: formation of the yeast Cbf1-Met4-Met28 complex is regulated through Met28 stimulation of Cbf1 DNA binding.
Kuras L; Barbey R; Thomas D
EMBO J; 1997 May; 16(9):2441-51. PubMed ID: 9171357
[TBL] [Abstract][Full Text] [Related]
23. The bHLH factors, dHAND and eHAND, specify pulmonary and systemic cardiac ventricles independent of left-right sidedness.
Thomas T; Yamagishi H; Overbeek PA; Olson EN; Srivastava D
Dev Biol; 1998 Apr; 196(2):228-36. PubMed ID: 9576835
[TBL] [Abstract][Full Text] [Related]
24. Human heart LIM protein activates atrial-natriuretic-factor gene expression by interacting with the cardiac-restricted transcription factor Nkx2.5.
Zheng B; Han M; Wen JK; Zhang R
Biochem J; 2008 Feb; 409(3):683-90. PubMed ID: 17927564
[TBL] [Abstract][Full Text] [Related]
25. Human homologue of maid: A dominant inhibitory helix-loop-helix protein associated with liver-specific gene expression.
Terai S; Aoki H; Ashida K; Thorgeirsson SS
Hepatology; 2000 Aug; 32(2):357-66. PubMed ID: 10915743
[TBL] [Abstract][Full Text] [Related]
26. SOX18 directly interacts with MEF2C in endothelial cells.
Hosking BM; Wang SC; Chen SL; Penning S; Koopman P; Muscat GE
Biochem Biophys Res Commun; 2001 Sep; 287(2):493-500. PubMed ID: 11554755
[TBL] [Abstract][Full Text] [Related]
27. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
28. The basic-helix-loop-helix transcription factor HAND2 directly regulates transcription of the atrial naturetic peptide gene.
Thattaliyath BD; Firulli BA; Firulli AB
J Mol Cell Cardiol; 2002 Oct; 34(10):1335-44. PubMed ID: 12392994
[TBL] [Abstract][Full Text] [Related]
29. Human eHAND, but not dHAND, is down-regulated in cardiomyopathies.
Natarajan A; Yamagishi H; Ahmad F; Li D; Roberts R; Matsuoka R; Hill S; Srivastava D
J Mol Cell Cardiol; 2001 Sep; 33(9):1607-14. PubMed ID: 11549340
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of embryonic transcription factors in right ventricular hypertrophy.
Bär H; Kreuzer J; Cojoc A; Jahn L
Basic Res Cardiol; 2003 Sep; 98(5):285-94. PubMed ID: 12955401
[TBL] [Abstract][Full Text] [Related]
31. Myogenic differentiation in atrium-derived adult cardiac pluripotent cells and the transcriptional regulation of GATA4 and myogenin on ANP promoter.
Kamrul Hasan M; Komoike Y; Tsunesumi S; Nakao R; Nagao H; Matsuoka R; Kawaguchi N
Genes Cells; 2010 May; 15(5):439-54. PubMed ID: 20384792
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
33. A BMAL1 mutant with arginine 91 substituted with alanine acts as a dominant negative inhibitor.
Hosoda H; Motohashi J; Kato H; Masushige S; Kida S
Gene; 2004 Sep; 338(2):235-41. PubMed ID: 15315827
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the estrogen receptor alpha minimal promoter by Sp1, USF-1 and ERalpha.
deGraffenried LA; Hopp TA; Valente AJ; Clark RA; Fuqua SA
Breast Cancer Res Treat; 2004 May; 85(2):111-20. PubMed ID: 15111769
[TBL] [Abstract][Full Text] [Related]
35. Autoactivation of Xenopus MyoD transcription and its inhibition by USF.
Lun Y; Sawadogo M; Perry M
Cell Growth Differ; 1997 Mar; 8(3):275-82. PubMed ID: 9056669
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional repression by the basic helix-loop-helix protein Dec2: multiple mechanisms through E-box elements.
Fujimoto K; Hamaguchi H; Hashiba T; Nakamura T; Kawamoto T; Sato F; Noshiro M; Bhawal UK; Suardita K; Kato Y
Int J Mol Med; 2007 Jun; 19(6):925-32. PubMed ID: 17487425
[TBL] [Abstract][Full Text] [Related]
37. The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling.
Muñoz JP; Collao A; Chiong M; Maldonado C; Adasme T; Carrasco L; Ocaranza P; Bravo R; Gonzalez L; Díaz-Araya G; Hidalgo C; Lavandero S
Biochem Biophys Res Commun; 2009 Oct; 388(1):155-60. PubMed ID: 19654000
[TBL] [Abstract][Full Text] [Related]
38. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription.
Tapscott SJ
Development; 2005 Jun; 132(12):2685-95. PubMed ID: 15930108
[TBL] [Abstract][Full Text] [Related]
39. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level.
Feng B; Chen S; Chiu J; George B; Chakrabarti S
Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1119-26. PubMed ID: 18413674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]